The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
A 2019 update on TSH-secreting pituitary adenomas
Abstract
Thyrotropin-secreting pituitary adenomas (TSH-omas) present with signs and symptoms of hyperthyroidism and they are characterized by elevated serum levels of free thyroid hormones with measurable TSH levels. TSH-omas are very infrequent, accounting for less than 1% of all pituitary adenomas, thus representing a very rare cause of hyperthyroidism. For this reason, data collected on these rare disorders are relatively few, but some new researches shed new light on the etiopathogenesis, the diagnosis and the treatment of such a remarkable disease. Since the same biochemical picture is present in the syndromes of thyroid hormone resistance (RTH), in particular in the form of pituitary RTH, failure in distinguishing these clinical entities may lead to improper patient management. Conversely, early diagnosis and correct treatment of TSH-omas may prevent the occurrence of neurological and endocrinological complications, thus leading to a better rate of cure. In the present short review article, the most relevant recent advances in the pathophysiology of TSH-omas are described.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment for TSH-omas involves neurosurgical intervention, and corticosteroid therapy is used to treat Addison's disease.69,71,85”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [71]
In the citing paper
“Treatment for TSH-omas involves neurosurgical intervention, and corticosteroid therapy is used to treat Addison's disease.69,71,85”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [71]
Citations
Cites
Daly, A., Tichomirowa, M. A., Pétrossians, P., Heliövaara, E., Jaffrain‐Rea, M., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Brücker-Davis, F., Oldfield, E. H., Skarulis, M. C., Doppman, J. L., & Weintraub, B. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5505 · Cited by 304
Pitfalls in the measurement and interpretation of thyroid function tests
Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.003 · Cited by 282
Beck‐Peccoz, P., Lania, A. G., Beckers, A. M., Chatterjee, K., & Wémeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000351007 · Cited by 279
Self-citationThe changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
Socin, H., Chanson, P., Delemer, B., Tabarin, A., Rohmer, V, Mockel, J., Stevenaert, A., & Beckers, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480433 · Cited by 274
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00119 · Cited by 258
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
Önnestam, L., Berinder, K., Burman, P., Dahlqvist, P., Engström, B. E., Wahlberg, J., & Nyström, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3362 · Cited by 148
Losa, M., Giovanelli, M. A., Persani, L., Mortini, P., Faglia, G., & Beck‐Peccoz, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768879 · Cited by 145
Self-citationYamada, S., Fukuhara, N., Horiguchi, K., Yamaguchi‐Okada, M., Nishioka, H., Takeshita, A., Takeuchi, Y., Itô, J., & Inoshita, N. (2014) · Journal of neurosurgery · doi:10.3171/2014.7.jns1471 · Cited by 143
Ando, S., Sarlis, N. J., Oldfield, E. H., & Yen, P. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7984 · Cited by 115
Research works printed but not linked: 2
- Beck-Peccoz P, Lania A, Persani L (2015) Chapter 24. TSH-producing adenomas. In: Jameson JL, DeGroot LJ (eds) Endocrinology, 7th edn. W.B. Saunders Pub, Philadelphia, pp 266–274
- Gurnell M, Visser TJ, Beck-Peccoz P, Chatterjee VKK (2015) Resistance to thyroid hormone: in endocrinology, adult and pediatric. In: Jameson LJ, DeGroot LJ (eds), 7th edn, vol II. Elsevier, Philadelphia pp 1648–1665
Cited by
Sorted by citations
Pituitary Adenomas: From Diagnosis to Therapeutics
Banskota, S., & Adamson, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050494 · Cited by 71
Structure and Function of Somatostatin and Its Receptors in Endocrinology
Zhang, B., Li, X., & Wu, Z. B. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae022 · Cited by 42
Luo, P., Zhang, L., Yang, L., An, Z., & Tan, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.580264 · Cited by 35
Gatto, F., Arvigo, M., & Ferone, D. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01335-0 · Cited by 34
Mimoto, M. S., & Refetoff, S. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01084-9 · Cited by 28
Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test
Han, R., Shen, L., Zhang, J., Xie, J., Fang, W., Sun, Q., Bian, L., Zhou, Y., Wang, S., Ning, G., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0470 · Cited by 26
Castro, M. A., Corrales, E. P., Millán, J. M. S., Rebolleda, G., Pian, H. G., Ruz‐Caracuel, I., Santos, G. D. L., Urzaiz, L. L., Escobar-Morreale, H. F., & Berrocal, V. R. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.11.001 · Cited by 24
Cosecreting TSH/GH pituitary adenomas—an 8-year experience in a single tertiary center
Li, X., Lynch, L., Xing, H., Wang, Z., Zhu, J., Deng, K., Wang, R., Yao, Y., & Lian, X. (2020) · Pituitary · doi:10.1007/s11102-020-01064-w · Cited by 17
Yoon, J. H., Choi, W., Park, J. Y., Hong, A. R., Kim, S. S., Kim, H. K., & Kang, H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00839-x · Cited by 16
Fu, J., Wu, A., Wang, X., & Guan, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00523 · Cited by 16
Li, X., Zhao, B., Hou, B., Wang, J., Zhu, J., Yao, Y., & Lian, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.619161 · Cited by 16
Refractory hypothyroidism: unraveling the complexities of diagnosis and management
Quiroz-Aldave, J. E., Concepción-Zavaleta, M. J., Durand-Vásquez, M. D. C., Concepción-Urteaga, L. A., Gamarra-Osorio, E. R., Suárez-Rojas, J., Rafael-Robles, L. D. P., Paz-Ibarra, J., & Román-González, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.003 · Cited by 14
Yang, Y., Liu, J., Deng, K., Lü, L., Zhu, H., Lian, X., Bao, X., Duan, L., & Yao, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.771673 · Cited by 13
Thyrotropin-secreting tumor “TSH-PitNET”: From diagnosis to treatment
Briet, C., Suteau, V., Illouz, F., & Rodien, P. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.004 · Cited by 12
Update on vertebral fractures in pituitary diseases: from research to clinical practice
Carrone, F., Ariano, S. A., Piccini, S., Milani, D., Mirani, M., Balzarini, L., Lania, A. G., & Mazziotti, G. (2021) · HORMONES · doi:10.1007/s42000-021-00275-5 · Cited by 11
Self-citationEffects of Anterior Pituitary Adenomas’ Hormones on Glucose Metabolism and Its Clinical Implications
Li, M., Zhang, J., Yang, G., Zhang, J., Han, M., Zhang, Y., & Liu, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s397445 · Cited by 10
Challenging diagnosis of resistance to thyroid hormone in a patient with pituitary adenoma
Cunha, N. C., Gomes, L., & Bastos, M. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-229430 · Cited by 10
Deng, F., Yang, Z., Zhang, Y., Wang, Y., Hu, J., & Zhang, F. (2021) · Brain and Behavior · doi:10.1002/brb3.2081 · Cited by 10
Şen, H. E., Ceylan, E. C., Atayev, S., Sözen, M., Bayrak, B. Y., Çetinarslan, B., Yonca Akgoz, A. N. I. K., Içli, A. D., Çabuk, B., Anık, İ., et al. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.09.027 · Cited by 9
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop
Yuen, K. C. J., Ghalib, L. M., Buchfelder, M., Hughes, J. N., Langlois, F., & Molitch, M. E. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.12.014 · Cited by 9
Timmons, J. G., & Mukhopadhyay, B. (2020) · HORMONES · doi:10.1007/s42000-020-00180-3 · Cited by 8
Liu, J., Yang, Y., Duan, L., Chai, X., Zhu, H., Deng, K., Lian, X., & Yao, Y. (2023) · Clinical Endocrinology · doi:10.1111/cen.14921 · Cited by 8
Headache in pituitary adenomas: frequency, characteristics and outcome after treatment
Scaf, C. R., Altoé, A., Ventura, N., Vincent, M. B., Kasuki, L., & Gadelha, M. R. (2025) · Pituitary · doi:10.1007/s11102-025-01504-5 · Cited by 7
Liu, J., Yang, Y., Duan, L., Chai, X., Zhu, H., Deng, K., Lian, X., & Yao, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061029 · Cited by 7
Heo, J.-R., Suh, Y.-L., Kim, S. H., Kong, D.-S., Nam, D.-H., Lee, W., Kim, S. T., Hong, S.-D., Ryu, S., Lee, Y.-B., et al. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1877 · Cited by 4
Liu, J., Liu, J., Chai, X., Zhu, H., Xing, B., Lian, W., Lian, X., Duan, L., Deng, K., & Yao, Y. (2025) · Endocrine · doi:10.1007/s12020-025-04298-5 · Cited by 6
Recent advancements in the molecular biology of pituitary adenomas
Zheng, A. C., Wang, E., & Aghi, M. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2082942 · Cited by 7
A rare pituitary tumor associated with hyperthyroidism and acromegaly
Li, L., Meng, L., Liu, Y., Tamrakar, R., Yang, X., Liang, X., Zhou, J., Xian, J., Huang, Z., & Qin, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072647 · Cited by 6
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas
Lenders, N. F., & McCormack, A. I. (2023) · Pituitary · doi:10.1007/s11102-023-01312-9 · Cited by 6
Somatostatin receptors and the associated intracellular machinery: the two sides of the coin
Campana, C., Iyer, A. M., Ferone, D., Gatto, F., & Hofland, L. J. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0298 · Cited by 6
Ren, X., Wang, X., Chen, G., Liu, X., Guo, H., & Li, M. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01357-8 · Cited by 5
Sözen, M., Bayrak, B. Y., Selek, A., Şen, H. E., Çetinarslan, B., Cantürk, Z., Civriz, A. H., Balcı, S., Gezer, E., Köksalan, D., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03480-x · Cited by 5
Vasikaran, S. D., & Loh, T. P. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00243 · Cited by 5
Management of pituitary tumors in pregnancy
Glezer, A., Jallad, R., Machado, M. C., & Bronstein, M. (2021) · Pituitary Tumors · doi:10.1016/b978-0-12-819949-7.00049-4
Central hyperthyroidism combined with Graves' disease: case series and review of the literature
Mo, C., Chen, H., Zhang, Q., Guo, Y., & Zhong, L. (2023) · European Thyroid Journal · doi:10.1530/etj-22-0223 · Cited by 5
TSH-secreting pituitary adenomas and bone
Losa, M., Vassallo, A., Frara, S., Mortini, P., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01467-z · Cited by 5
Pituitary microadenomas — current diagnostic and treatment methods
Astafyeva, L. I., Кадашев, Б. А., Sidneva, Y., Chernov, I. V., & Kalinin, P. L. (2020) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202084021110 · Cited by 4
Simultaneous Coexistence of Thyrotropin‐Prolactin‐Secreting Adenoma and Papillary Thyroid Carcinoma
Safi, S., Benabdelfedil, Y., Derrou, S., & Guendouz, F. E. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/6564765 · Cited by 4
Genetics of Pituitary Adenomas
Bogusławska, A., Gilis‐Januszewska, A., & Korbonits, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_4 · Cited by 4
Yan, H., Yan, C., Mao, J., & Jin, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1121140 · Cited by 4
Metabolic Syndrome Components in Patients with Pituitary Adenoma
González-Almazán, J. A., Cortés-Contreras, A. P., Flores-Rabasa, R., Méndez-García, L. A., Escobedo, G., Navarro-Olvera, J. L., & Carrillo-Ruiz, J. D. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2209-0538 · Cited by 3
Jocys, J., Laukienė, R., & Tamosiunas, A. E. (2025) · Diagnostics · doi:10.3390/diagnostics15111313 · Cited by 3
Peng, G., Guo, C., Lv, Y., Li, D., Zhou, L., Shen, R., Chen, Y., Zheng, X., Sun, Z., Zheng, H., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01220-2 · Cited by 3
Zhao, R., Fan, K., & Wan, W. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01398-z · Cited by 3
REVIEW OF SARS-CORONAVIRUS-2 REPERCUSSIONS ON THYROID GLAND IN THE CONTEXT OF HYPERTHYROIDISM
Singh, S. V., Monika, Mazumder, R., & Mazumder, A. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.47937 · Cited by 3
Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients
Аршалуйсовна, Т. Д., Przhiyalkovskaya, E. G., Belaya, Z. E., Grigoriev, A. Y., Неронович, А. В., Mamedova, E., Rozhinskaya, L. Y., Лапшина, А. М., Pigarova, E. A., Dzeranova, L. K., et al. (2023) · Problems of Endocrinology · doi:10.14341/probl13325 · Cited by 3
Klinisch aktive Hypophysentumoren
Unger, N., Theodoropoulou, M., & Schilbach, K. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01729-9 · Cited by 3
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.11.001 · Cited by 3
Mo, C., Chen, H., Xu, J., Guo, Y., Wang, Y., Li, Z., Tong, T., Gui, S., & Zhong, L. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.01.013 · Cited by 2
Koo, T. H., & Gharib, H. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.09.015 · Cited by 2
Tratamiento médico del hipertiroidismo
Hernández, J. J. C., SÁNCHEZ-MARCOS, A. I., Recio‐Córdova, J. M., IGLESIAS-LÓPEZ, R. A., & ALVÁREZ, M. T. M. (2019) · Revista ORL · doi:10.14201/orl.20957 · Cited by 2
Morgante, C., Guaraldi, F., Asioli, S., Mazzatenta, D., Papi, G., & Pontecorvi, A. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230623161631 · Cited by 2
Liao, W., Waisayanand, N., Fanhchaksai, K., Visser, W. E., Meima, M. E., & Wejaphikul, K. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae140 · Cited by 2
Huang, Y., Wen, X., Liang, X., & Xu, L. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1436400 · Cited by 2
Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis
Agrawal, N., Kim, H. H., Wright, K. E., & Mehta, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_10 · Cited by 2
Non-surgical Interventions for Pituitary Lesions
Suda, N. (2022) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.12.004 · Cited by 2
Thyrotrophin-Secreting Pituitary Adenomas
Greenman, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00012-3 · Cited by 2
Nakaya, M., Tamura, R., Takahara, K., Senuma, T., Yoshida, K., Kitamura, Y., Ueda, R., & Toda, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1162733 · Cited by 2
Castro, M. A., Berrocal, V. R., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2023.07.007 · Cited by 2
Carides, M., Mehta, R., Louw, J. C., & Mohamed, F. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0136 · Cited by 4
Kwinta, B. M. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.148 · Cited by 1
Kopanos, S., Knappe, U. J., Moeller, A. S., Scheel, S. N., & Feldkamp, J. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2762-7986 · Cited by 1
de Souza, P. M. A., Morais, J. R. R., Morais, K. V. R., Brito, J. D. S., & Faria, T. A. (2020) · Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo · doi:10.26432/1809-3019.2020.65.035 · Cited by 1
Endocrinological diagnosis and treatment of TSH-secreting pituitary adenomas
Maione, L., Li, C. Y., & Chanson, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00033-0 · Cited by 1
Maia, A., Rodrigues, C. C., Ribeiro, M. I., & Amaral, C. (2023) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2023_003905 · Cited by 1
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.06.004 · Cited by 2
Castinetti, F., Albarel, F., Cuny, T., Morange, I., Vermalle, M., & Brue, T. C. (2024) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(24)49086-7 · Cited by 1
Thyroiditis Developing Post Initiation of Octreotide in a Case of TSH Secreting Tumor
Kulshreshtha, B. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.90 · Cited by 1
Bao, L. H., Đức, N. M., Phan, C. C., My, T. T., Thang, T. V., & Nam, T. Q. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/5573231 · Cited by 1
Hyperthyroidism and Thyrotoxicosis
Bartalena, L., & Vitti, P. (2025) · Journal of Medical Clinical Case Reports · doi:10.47485/2767-5416.1124 · Cited by 1
Sindrome da resistenza agli ormoni tiroidei: dalla genetica alla gestione clinica
Colombo, P., Ariano, S. A., & Lania, A. G. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00836-1
Self-citationEndocrinological outcome of transsphenoidal surgery in pituitary adenomas
Elbelt, U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00041-x
Thyreotroop adenoom van de hypofyse: een zeldzame oorzaak van hyperthyreoïdie
Develtere, T., Duyck, F., Vanhauwaert, D. J., Dedeurwaerdere, F., & Spincemaille, K. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.131
Hyperthyreose: Ursachen, Diagnostik, Behandlung
Grußendorf, M. (2021) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-021-0261-5
Ariyawansa, C., Lim, E. M., & Kodali, V. R. R. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab196
Santaliestra, M. J. C. (2022) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2021.05.002
Ramos-Levi, A. M., Moreno, N. A., & Marazuela, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_12
Peverelli, E., Giardino, E., Treppiedi, D., Catalano, R., Mangili, F., & Mantovani, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_8
Peng, G., Guo, C., Lv, Y., Zhou, L., Shen, R., Chen, Y., Zheng, X., Sun, Z., Zheng, H., & Long, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1802750/v1
A Case Report of a Thyrotropin-Secreting Pituitary Macroadenoma
Atwi, B., Melhem, Z., Yaacoub, B., Awada, M., & Issa, Z. A. (2022) · Cureus · doi:10.7759/cureus.27216
Neoplasms of the Endocrine Glands and Pituitary Neoplasms
Feng, R., Gandhi, C. D., Pain, M., & Post, K. D. (2022) · Holland‐Frei Cancer Medicine · doi:10.1002/9781119000822.hfcm080.pub2
Pigni, S., & Lania, A. G. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01211-y
Self-citationMixed Thyrotropin-Secreting Pituitary Adenoma Coexisted with Graves' Disease: a case reportPreprint
Huang, Y., Wen, X., Liang, X., & Xu, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2739891/v1
Can a novel drug dose be used for T3 suppression test?
Çetin, S., Güven, M., Bolayır, B., Şimşek, M., Soylu, H., Geneş, D., Ay, N., & Diri, H. (2023) · Endocrine · doi:10.1007/s12020-023-03445-0
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Neurocirugía · doi:10.1016/j.neucir.2023.07.002
Zhao, R., Fan, K., & Wan, W. (2023) · Figshare · doi:10.6084/m9.figshare.23972843
Zhao, R., Fan, K., & Wan, W. (2023) · Figshare · doi:10.6084/m9.figshare.23972846
Kasemsripitak, S., Jaruratanasirikul, S., Saengkaew, T., & Wejaphikul, K. (2024) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.20241055
Castinetti, F., Albarel, F., Cuny, T., Morange, I., Vermalle, M., & Brue, T. C. (2024) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(24)49205-x
TSHoma: A Rare cause of Pituitary Adenoma
Mall, D., Koirala, T., Bisht, A., Wasti, K., & Nepal, R. (2024) · Journal of Diabetes and Endocrine Association of Nepal · doi:10.3126/jdean.v8i3.65856
Early identification of postoperative remission for thyrotropin‐secreting adenomas
Fan, L., Wang, Z., Sun, W., Cui, Q., Wu, W., Xiang, B., Ma, Z., Wu, Y., Wang, Y., Zhao, Y., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15066
Variante no reportada del gen THRB en un paciente con resistencia a hormonas tiroideas
Builes-Montaño, C. E., Arroyo-Ripoll, O. F., & Saldarriaga, J. E. C. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.2.846
Lin, C., Lee, H., Chen, C., Sung, F., & Su, T. (2024) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2024.100476
Gruneisen, E., & Rivera, J. A. (2025) · Case Reports in Endocrinology · doi:10.1155/crie/5103475
Leung, C., Inder, W. J., Ong, B., & Brooks, E. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf069
Kopanos, S., Knappe, U. J., Moeller, A. S., Yasin, A., & Feldkamp, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7143177/v1
Neuroanesthesia for pituitary surgery
Solari, D., Cavallo, L. M., Domenico, C. D., & Cafiero, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22273-3.00016-x
Yoon, J. H., Choi, W., Park, J. Y., Hong, A. R., Kim, S. S., Kim, H. K., & Kang, H.-C. (2021) · Figshare · doi:10.6084/m9.figshare.16544205
Peng, G., Guo, C., Lv, Y., Li, D., Zhou, L., Shen, R., Chen, Y., Zheng, X., Sun, Z., Zheng, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603718
Peng, G., Guo, C., Lv, Y., Li, D., Zhou, L., Shen, R., Chen, Y., Zheng, X., Sun, Z., Zheng, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603715
Metadata
- Authors
- Beck-Peccoz, P., Giavoli, C., & Lania, A.
- Affiliations
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Humanitas University (IT)
- Corresponding author
- Lania, A.
- ORCID
- Venue
- Journal of Endocrinological Investigation
- Published
- 2019-06-07
- Volume
- 42
- Issue
- 12
- Pages
- 1401-1406
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2954800995
- Cited by
- 111
- References
- 44
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 27 · 2022: 14 · 2021: 17 · 2020: 12 · 2019: 3
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- TSH-secreting pituitary adenoma, TSHoma, hyperthyroidism, thyroid hormone resistance, etiopathogenesis, diagnosis, treatment, neurological complications
- MeSH terms
- Adenoma, Humans, Hyperthyroidism, Pituitary Neoplasms, Thyroid Hormones, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review